15 results
10-K
2021 FY
EX-14.1
UNCY
Unicycive Therapeutics Inc
31 Mar 22
Annual report
6:18am
, including laws prohibiting bribery, corruption or the conduct of business with specified individuals, companies or countries. The fact that in some countries
10-K
2021 FY
UNCY
Unicycive Therapeutics Inc
31 Mar 22
Annual report
6:18am
is particularly serious in emerging markets, where corruption is often prevalent and where many of the third parties on which we rely do not have … and reporting obligations.
We are subject to U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws and anti
10-Q
2021 Q2
UNCY
Unicycive Therapeutics Inc
16 Aug 21
Quarterly report
6:06am
as well. This risk is particularly serious in emerging markets, where corruption is often prevalent and where many of the third parties on which we … and reporting obligations.
We are subject to U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws and anti-money
424B4
3ficd5hg850ml j5yc
14 Jul 21
Prospectus supplement with pricing info
1:59pm
S-1/A
naq0uli
7 Jun 21
IPO registration (amended)
7:01am
S-1
2auku2tgmp7pn
21 May 21
IPO registration
4:07pm
DRS/A
scrlzjnf42k57
29 Apr 21
Draft registration statement (amended)
12:00am
DRS/A
fhb76mcjnq17fsip
18 Feb 21
Draft registration statement (amended)
12:00am
DRS/A
ndteyzb s73znn
2 Nov 20
Draft registration statement (amended)
12:00am
DRS
apn kxp1tls
15 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next